14th December 2021
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces a conditional subscription to raise £1.65 million with Lanstead Capital Investors L.P.
Download News